Black Rock Inc. Eli Lilly & CO Call Options Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $32 Million - $40.2 Million	-44,200 Reduced 34.89%	82,500 $74.7 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $75 Million - $100 Million	126,700 New	126,700 $98.6 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $14 Million - $19.3 Million	32,200 Added 21.35%	183,000 $98.3 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $52.9 Million - $70.7 Million	150,800 New	150,800 $70.7 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $62.5 Million - $72.8 Million	-194,400 Reduced 33.92%	378,700 $139 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8.89 Million - $10.1 Million	30,000 Added 5.52%	573,100 $185 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $83.2 Million - $97.7 Million	298,600 Added 122.13%	543,100 $176 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $24.9 Million - $30.9 Million	110,700 Added 82.74%	244,500 $67.5 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $29.7 Million - $36.5 Million	133,800 New	133,800 $30.9 Million

4,471

779M

16.9M

12.6M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.